Suppressing apoptosis with milrinone simulating extracorporeal circulation: a pilot study

Area of Science:

• Cardiovascular Science
• Cellular Biology
• Surgical Research

Background:

• Ischemia/reperfusion injury is a significant concern after cardioplegia, potentially inducing cardiomyocyte apoptosis.
• Evaluating ex vivo models is crucial for understanding myocardial injury mechanisms.
• Simulated cardioplegia and reperfusion conditions provide a controlled environment for studying these effects.

Purpose of the Study:

• To assess an ex vivo microperfusion model for human myocardium under simulated cardioplegia and reperfusion.
• To investigate the anti-apoptotic properties of milrinone, a phosphodiesterase 3 inhibitor.

Main Methods:

• Human cardiac biopsies were subjected to ex vivo microperfusion with varying durations of cardioplegia/reperfusion.
• Three groups were studied: untreated controls, treated controls, and milrinone-treated group.
• Apoptosis was quantified using anti-activated caspase-3 and PARP-1 cleavage immunostaining.

Main Results:

• A time-dependent increase in apoptotic cardiomyocytes was observed in untreated and treated control groups.
• Milrinone treatment significantly suppressed apoptosis in the ex vivo human myocardium.
• The percentage of apoptotic cells was significantly lower in the milrinone group compared to controls.

Conclusions:

• Milrinone demonstrates significant anti-apoptotic effects in an ex vivo model of myocardial ischemia/reperfusion.
• These findings suggest a potential protective role for milrinone against ischemia/reperfusion injury.
• Further clinical studies are warranted to explore milrinone's benefits in surgical settings.